The SNAP trial: A randomised placebo-controlled trial of nicotine replacement therapy in pregnancy - Clinical effectiveness and safety until 2 years after delivery, with economic evaluation

Health Technology Assessment

Volumn 18, Issue 54, 2014, Pages 1-128

  Cooper, Sue ^a   Lewis, Sarah ^a   Thornton, James G ^a,i   Marlow, Neil ^b   Watts, Kim ^a   Britton, John ^a   Grainge, Matthew J ^a   Taggar, Jaspal ^a   Essex, Holly ^c   Parrott, Steve ^c   Dickinson, Anne ^a   Whitemore, Rachel ^a   Coleman, Tim ^a   Coughtrie, Michael ^l   Mannion, Clare ^l   Godfrey, Christine ^l   Brocklehurst, Peter ^l   Coupland, Carol ^l   Hajek, Peter ^l   Maguire, Sue ^l   Murphy, Michael ^l   Peacock, Janet ^l   Butler, Christopher ^l   Field, David ^l   Khan, Khalid ^l   Brown, Janet ^l   Davis, Yvette ^l   Dixon, Caroline ^l   Holloway, Fiona ^l   Lakin, Joanne ^l   Platts, Jayne ^l   Rashid, Farzana ^l   Redford, Amanda ^l   Taylor, Cara ^l   Allsop, Jonathan ^d   Cunningham, Simon ^e   Glass, Karen ^f   Hall, Vince ^g   Ismail, Khaled ^h   Ramsay, Margaret ⁱ   Appleby, Sheena ^l   Bailey, Denise ^l   Gustard, Linda ^l   Haworth, Emma ^l   Hopps, Grace ^l   Lindley, Amanda ^l   Kettle, Chris ^l   Pearce, Colleen ^l   Sexton Bradshaw, Dymphna ^l   Savage, Julia ^l   Smith, Sandra ^l   Taylor, Sheila ^l   Whitham, Alison ^l   Brady, Barbara ^l   Battlemuch, Michelle ^l   Dudley, Wendy ^l   Edwards, Rochelle ^l   Frith, Lorraine ^l   Hari, Indu ^l   Holden, Catriona ^l   Hoskyns, Linda ^l   Jackson, Paul ^l   Rajaratnam, Giri ^l   Richardson, Deborah ^l   Wade, Lucy ^l   Whittaker, Maureen ^l   Cook, Bernie ^j   Hodgson, Sheila ^j   Humphries, Lisa ^j   Sanders, Bernie ^j   Simpkins, Dan ^a   Vaz, Luis ^a   Kurlak, Yvanna ^a   Randall, Clare ^a   Taylor, John ^a   Sharp, Sheila ^k   more..

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d DERBY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e MID CHESHIRE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f SHERWOOD FOREST HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g MACCLESFIELD DISTRICT GENERAL HOSPITAL   (United Kingdom)

^h UNIVERSITY HOSPITALS OF NORTH MIDLANDS NHS TRUST   (United Kingdom)

ⁱ NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^j QMC Pharmacy   (United Kingdom)

^k UNIVERSITY OF DUNDEE   (United Kingdom)

^l University of Nottingham ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; COTININE; NICOTINE PATCH; PLACEBO; NICOTINE; NICOTINE GUM;

ABDOMINAL PAIN; ADULT; APGAR SCORE; ARTICLE; BEHAVIOR THERAPY; BIRTH WEIGHT; BODY HEIGHT; BRAIN HEMORRHAGE; CESAREAN SECTION; CHILD DEATH; CHILD DEVELOPMENT; CHILDBIRTH; CLINICAL EFFECTIVENESS; COMMUNICATION SKILL; CONGENITAL DISORDER; CONTROLLED STUDY; CONVULSION; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DEVELOPMENTAL DISORDER; DISABILITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ECLAMPSIA; ECONOMIC EVALUATION; FEMALE; FETUS OUTCOME; GENERAL PRACTITIONER; GESTATION PERIOD; HEADACHE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH STATUS; HUMAN; INTENTION TO TREAT ANALYSIS; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL SMOKING; MIDWIFE; MOTOR PERFORMANCE; NAUSEA; NECROTIZING ENTEROCOLITIS; NEWBORN DEATH; NICOTINE REPLACEMENT THERAPY; PHASE 4 CLINICAL TRIAL; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRENATAL PERIOD; PREVALENCE; PRIMARY MEDICAL CARE; PROBLEM SOLVING; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; SELF REPORT; SENSITIVITY ANALYSIS; SKIN MANIFESTATION; SMOKING; SMOKING CESSATION; SPONTANEOUS ABORTION; STILLBIRTH; TOBACCO DEPENDENCE; UNITED KINGDOM; UTERINE CERVIX DISEASE; VAGINA BLEEDING; VAGINAL DELIVERY; VOMITING; ADVERSE EFFECTS; CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; EPIDEMIOLOGY; INFANT; INTRADERMAL DRUG ADMINISTRATION; MULTICENTER STUDY; NEWBORN; OUTCOME ASSESSMENT; PREGNANCY COMPLICATIONS; PRESCHOOL CHILD; PREVENTION AND CONTROL; PROCEDURES; STATISTICS AND NUMERICAL DATA; TIME;

ADMINISTRATION, CUTANEOUS; ADULT; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; ENGLAND; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; NICOTINE; OUTCOME ASSESSMENT (HEALTH CARE); PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; SMOKING; SMOKING CESSATION; TIME; TOBACCO USE CESSATION PRODUCTS;

EID: 84907320419     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta18540     Document Type: Article

References (88)

1. Royal College of Physicians. Smoking and the Young. London: Royal College of Physicians; 1992.
2. Green NS, Damus K, Simpson JL, Iams J, Reece EA, Hobel CJ, et al. Research agenda for preterm birth: recommendations from the March of Dimes. Am J Obstet Gynecol 2005; 193: 626-35. http://dx. doi. org/10. 1016/j. ajog. 2005. 02. 106.
3. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. New Engl J Med 2008; 359: 61-73. http://dx. doi. org/10. 1056/NEJMra0708473.
4. The NHS Information Centre. Infant Feeding Survey 2010. Early Results. The NHS Information Centre for Health and Social Care; 2011. URL: www. hscic. gov. uk/catalogue/PUB00648 (accessed 9 April 2014).
5. Mohsin M, Bauman AE. Socio-demographic factors associated with smoking and smoking cessation among 426, 344 pregnant women in New South Wales, Australia. BMC Public Health 2005: 5: 138. http://dx. doi. org/10. 1186/1471-2458-5-138.
6. Jensen KE, Jensen A, Nohr B, Kjaer SK. Do pregnant women still smoke? A study of smoking patterns among 261, 029 primiparous women in Denmark 1997-2005. Acta Obstet Gyn Scand 2008; 87: 760-7. http://dx. doi. org/10. 1080/00016340802179814.
7. Centers for Disease Control and Prevention. Smoking during pregnancy-United States, 1990-2002. MMWR Morb Mortal Wkly Rep 2004; 53: 911-15.
8. Schneider S, Maul H, Freerksen N, Potschke-Langer M. Who smokes during pregnancy? An analysis of the German Perinatal Quality Survey 2005. Public Health 2008; 122: 1210-16. http://dx. doi. org/10. 1016/j. puhe. 2008. 02. 011.
9. Martinez-Frias ML, Rodriguez-Pinilla E, Bermejo E. Tobacco smoking during pregnancy in Spain: an analysis according to years, autonomous communities and maternal characteristics. Med Clin (Barc) 2005; 124: 86-92.
10. Polanska K, Hanke W, Sobala W, Broszkiewicz M. Smoking cessation intervention during pregnancy in a Polish urban community-what is the target population? Tob Induced Dis 2002; 1: 121-8. http://dx. doi. org/10. 1186/1617-9625-1-2-121.
11. Oncken CA, Dietz PM, Tong VT, Belizan JM, Tolosa JE, Berghella V, et al. Prenatal tobacco prevention and cessation interventions for women in low-and middle-income countries. Acta Obstet Gynecol Scand 2010; 89: 442-53. http://dx. doi. org/10. 3109/00016341003678450.
12. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008-the MPOWER Package. Geneva: World Health Organization; 2008.
13. Leonardi-Bee J, Jere ML, Britton J. Exposure to parental and sibling smoking and the risk of smoking uptake in childhood and adolescence: a systematic review and meta-analysis. Thorax 2011; 66: 847-55. http://dx. doi. org/10. 1136/thx. 2010. 153379.
14. Lumley J, Chamberlain C, Dowswell T, Oliver S, Oakley L, Watson L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2009; 3: CD001055.
15. Lumley J, Chamberlain C, Dowswell T, Oliver S, Oakley L, Watson L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2004; 4: CD001055. http://dx. doi. org/10. 1002/14651858. CD001055. pub3.
16. Naughton F, Prevost AT, Sutton S, Naughton F, Prevost AT, Sutton S. Self-help smoking cessation interventions in pregnancy: a systematic review and meta-analysis. Addiction 2008; 103: 566-79. http://dx. doi. org/10. 1111/j. 1360-0443. 2008. 02140. x.
17. Anonymous. Statistics on NHS Stop Smoking Services-England, April 2011 to March 2012. Health and Social Care Information Centre: Department of Health; 2013. URL: www. hscic. gov. uk/searchcatalogue?productid=7993&q=stop+smoking+services&sort=Relevance&size=10& page=1#top (accessed 13 June 2013).
18. Anonymous. NHS Maternity Statistics-England, 2010-2011. Health and Social Care Information Centre: Department of Health; 2013. URL: www. hscic. gov. uk/pubs/maternity1011 (accessed 13 June 2013).
19. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2008; 1: CD000146. http://dx. doi. org/10. 1002/14651858. CD000146. pub3.
20. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2007; 1: CD000031.
21. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2004; 4: CD000031.
22. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012; 4: CD006103.
23. Dempsey DA, Benowitz NL. Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf 2001; 24: 277-322. http://dx. doi. org/10. 2165/00002018-200124040-00005.
24. Batstra L, Hadders-Algra M, Neeleman J. Effect of antenatal exposure to maternal smoking on behavioural problems and academic achievement in childhood: prospective evidence from a Dutch birth cohort. Early Hum Develop 2003; 75: 21-33. http://dx. doi. org/10. 1016/j. earlhumdev. 2003. 09. 001.
25. Thapar A, Fowler T, Rice F, Scourfield J, van den BM, Thomas H, et al. Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am J Psychiatry 2003; 160: 1985-9. http://dx. doi. org/10. 1176/appi. ajp. 160. 11. 1985.
26. Benowitz NL, Dempsey DA, Goldenberg RL, Hughes JR, Dolan-Mullen P, Ogburn PL, et al. The use of pharmacotherapies for smoking cessation during pregnancy. Tob Control 2000; 9(Suppl. 3): iii91-4. http://dx. doi. org/10. 1136/tc. 9. suppl_3. iii91.
27. British Medical Association and Royal Pharmaceutical Society of Great Britain. British National Formulary. No. 45. London: BMA and RPS; 2003.
28. Anonymous. National Treatment Guidelines. 2013. URL: www. treatobacco. net/en/page_224. php (accessed 15 August 2013).
29. Wisborg K, Henriksen TB, Jespersen LB, Secher NJ. Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol 2000; 96: 967-71. http://dx. doi. org/10. 1016/S0029-7844(00)01071-1.
30. Kapur B, Hackman R, Selby P, Klein J, Koren G. Randomized, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy. Cur Ther Res 2001; 62: 274-8. http://dx. doi. org/10. 1016/S0011-393X(01)80011-4.
31. Hegaard HK, Kjaergaard H, Moller LF, Wachmann H, Ottesen B. Multimodal intervention raises smoking cessation rate during pregnancy. Acta Obstet Gyn Scand 2003; 82: 813-19. http://dx. doi. org/10. 1034/j. 1600-0412. 2003. 00221. x.
32. Coleman T, Chamberlain C, Cooper S, Leonardi-Bee J. Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis. Addiction 2011; 106: 52-61. http://dx. doi. org/10. 1111/j. 1360-0443. 2010. 03179. x.
33. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2012; 9: CD010078. http://dx. doi. org/10. 1002/14651858. CD010078.
34. Lumley J, Oliver SS, Chamberlain C, Oakley L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2004; 4: CD001055.
35. Lumley J, Oliver SS, Chamberlain C, Oakley L. Interventions for promoting smoking cessation during pregnancy Cochrane Database Syst Rev 2000; 2: CD001055.
36. Hotham ED, Gilbert AL, Atkinson ER. A randomised-controlled pilot study using nicotine patches with pregnant women. Addict Behav 2006; 31: 641-8. http://dx. doi. org/10. 1016/j. addbeh. 2005. 05. 042.
37. Pollak KI, Oncken CA, Lipkus IM, Lyna P, Swamy GK, Pletsch PK, et al. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prevent Med 2007; 33: 297-305. http://dx. doi. org/10. 1016/j. amepre. 2007. 05. 006.
38. Oncken C, Dornelas E, Greene J, Sankey H, Glasmann A, Feinn R, et al. Nicotine gum for pregnant smokers: a randomized controlled trial. Obstet Gynecol 2008; 112: 859-67. http://dx. doi. org/10. 1097/AOG. 0b013e318187e1ec.
39. Health Development Agency Expert Panel. Standard for Training in Smoking Cessation Treatments. London: Health Development Agency; 2003.
40. Windsor RA, Woodby LL, Miller TM, Hardin JM, Crawford MA, DiClemente CC. Effectiveness of Agency for Health Care Policy and Research clinical practice guideline and patient education methods for pregnant smokers in medicaid maternity care. Am J Obstet Gynecol 2000; 182: 68-75. http://dx. doi. org/10. 1016/S0002-9378(00)70492-3.
41. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002; 4: 149-59. http://dx. doi. org/10. 1080/14622200210123581.
42. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989; 84: 791-9. http://dx. doi. org/10. 1111/j. 1360-0443. 1989. tb03059. x.
43. McColl E, Jacoby A, Thomas L, Soutter J, Bamford C, Steen N, et al. Design and use of questionnaires: a review of best practice applicable to surveys of health service staff and patients. Health Technol Assess 2001; 5(31).
44. Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R, et al. Increasing response rates to postal questionnaires: systematic review. BMJ 2002; 324: 1183. http://dx. doi. org/10. 1136/bmj. 324. 7347. 1183.
45. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ 1998; 316: 736-41. http://dx. doi. org/10. 1136/bmj. 316. 7133. 736.
46. Squires J, Bricker D, Potter L. Revision of a parent-completed development screening tool: Ages and Stages Questionnaires. J Pediatr Psychol 1997; 22: 313-28. http://dx. doi. org/10. 1093/jpepsy/22. 3. 313.
47. Squires J and Bricker D. Ages and Stages Questionnaire: A Parent-Completed Child-Monitoring System. 3rd edn. Baltimore, MD: Paul H Brookes Publishing Co.; 2009.
48. Squires J, Twombly E, Bricker D, Potter L. ASQ-3 User's Guide for the Ages and Stages Questionnaires. 3rd edn. Baltimore, MD: Paul H Brookes Publishing Co.; 2009.
49. Report of Two Working Groups. Disability and Perinatal Care: Measurement of Health Status at Two Years. Oxford, England: National Perinatal Epidemiology Unit and Oxford Health Authority; 1995.
50. Jones HP, Guildea ZE, Stewart JH, Cartlidge PH. The Health Status Questionnaire: achieving concordance with published disability criteria. Arch Dis Child 2002; 86: 15-20. http://dx. doi. org/10. 1136/adc. 86. 1. 15.
51. Marlow N. Pulmonary outcomes for the extremely preterm infant. Biol Neonate 2000; 78: 239-40.
52. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005; 100: 299-303. http://dx. doi. org/10. 1111/j. 1360-0443. 2004. 00995. x.
53. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004; 3: CD000146.
54. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2002; 4: CD000146.
55. Pocock SJ, Assmann SE, Enos LE, Kasten LE. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems. Stat Med 2002; 21: 2917-30. http://dx. doi. org/10. 1002/sim. 1296.
56. Gates S, Brocklehurst P. How should randomised trials including multiple pregnancies be analysed? BJOG 2004; 111: 213-19. http://dx. doi. org/10. 1111/j. 1471-0528. 2004. 00059. x.
57. Hedeker D, Mermelstein RJ, Demirtas H. Analysis of binary outcomes with missing data: missing = smoking, last observation carried forward, and a little multiple imputation. Addiction 2007; 102: 1564-73. http://dx. doi. org/10. 1111/j. 1360-0443. 2007. 01946. x.
58. Anonymous. Handling missing data in randomised trials. Short course 14-15 March 2012. Cambridge: MRC Biostatistics Unit; 2012.
59. Coleman T, Thornton J, Britton J, Lewis S, Watts K, Coughtrie MW, et al. Protocol for the Smoking, Nicotine and Pregnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy. BMC Health Serv Res 2007; 7: 2. http://dx. doi. org/10. 1186/1472-6963-7-2.
60. Coleman T, Cooper S, Thornton JG, Grainge MJ, Watts K, Britton J, et al. A randomized trial of nicotine-replacement therapy patches in pregnancy. New Engl J Med 2012; 366: 808-18. http://dx. doi. org/10. 1056/NEJMoa1109582.
61. Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ, et al. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technol Assess 2002; 6(16).
62. Ruger JP, Lazar CM. Economic evaluation of pharmaco-and behavioral therapies for smoking cessation: a critical and systematic review of empirical research. Annu Rev Public Health 2012; 33: 279-305. http://dx. doi. org/10. 1146/annurev-publhealth-031811-124553.
63. Ruger JP, Emmons KM. Economic evaluations of smoking cessation and relapse prevention programs for pregnant women: a systematic review. Value Health 2008; 11: 180-90. http://dx. doi. org/10. 1111/j. 1524-4733. 2007. 00239. x.
64. Ruger JP, Weinstein MC, Hammond SK, Kearney MH, Emmons KM. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial. Value Health 2008; 11: 191-8. http://dx. doi. org/10. 1111/j. 1524-4733. 2007. 00240. x.
65. National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. 2008. URL: www. nice. org. uk/media/B52/A7/TAMethodsGuideUpdatedJune2008. pdf (accessed 8 August 2013).
66. National Institute for Health and Clinical Excellence. Smoking Cessation Services: Costing Report Implementing NICE Guidance. 2008. URL: www. nice. org. uk/nicemedia/live/11925/39719/39719. pdf (accessed 8 August 2013).
67. Curtis L. Unit Costs of Health and Social Care 2012. Canterbury: Personal Social Services Research Unit; 2012.
68. The Health and Social Care Information Centre. Prescription Cost Analysis England 2009. Leeds: The Health and Social Care Information Centre, Prescribing Support Unit; 2010.
69. Anonymous. NHS Monthly Remuneration Statistics. London: Pharmaceutical Services Negotiating Committee; 2013. URL: http://archive. psnc. org. uk/pages/archive. html (accessed 16 April 2014).
70. The NHS Staff Council. NHS Terms and Conditions of Service Handbook: Pay Circulars (AforC) 1 and 2/2013, Amendment Number 28. London: The NHS Staff Council; 2013.
71. Department of Health. NHS Reference Costs 2009-2010: Appendix NSRC01: NHS Trust Reference Cost Schedules. London: Department of Health; 2011. URL: www. gov. uk/government/publications/nhs-reference-costs-2009-2010 (accessed March 2013).
72. NHS Connecting for Health. Savings Realised by Different Types of Organisations Across the NHS Through the Use of the NHSmail SMS feature: GP Practice, Ayrshire. London: NHS Connecting for Health 2013. URL: www. connectingforhealth. nhs. uk/systemsandservices/nhsmail/about/benefits (cited March 2013).
73. The Health and Social Care Information Centre. Hospital Episode Statistics, Admitted Patient Care-England, 2009-10. Leeds: The Health and Social Care Information Centre; 2010. URL: www. hscic. gov. uk/pubs/hes0910 (accessed March 2013).
74. EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990; 16: 199-208. http://dx. doi. org/10. 1016/0168-8510(90)90421-9.
75. Chan OK, Sahota DS, Leung TY, Chan LW, Fung TY, Lau TK. Nausea and vomiting in health-related quality of life among Chinese pregnant women. Aust N Z J Obstet Gynaecol 2010; 50: 512-18. http://dx. doi. org/10. 1111/j. 1479-828X. 2010. 01216. x.
76. Haas JS, Jackson RA, Fuentes-Afflick E, Stewart AL, Dean ML, Brawarsky P, et al. Changes in the health status of women during and after pregnancy. J Gen Intern Med 2005; 20: 45-51. http://dx. doi. org/10. 1111/j. 1525-1497. 2004. 40097. x.
77. Black WC. The CE plane: a graphic representation of cost-effectiveness. Med Decis Making 1990; 10: 212-14. http://dx. doi. org/10. 1177/0272989X9001000308.
78. Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population study. Health Econ 1996; 5: 141-54. http://dx. doi. org/10. 1002/(SICI)1099-1050(199603) 5: 2<141:: AID-HEC189>3. 0. CO; 2-N.
79. Taylor M. Economic Analysis of Interventions for Smoking Cessation Aimed at Pregnant Women. NICE Guidance PH26. 2009. URL: http://guidance. nice. org. uk/PH26 (accessed 31 March 2014).
80. Seckerwalker R, Solomon L, Flynn B, Skelly J, Lepage S, Goodwin G, et al. Individualized smoking cessation counseling during prenatal and early postnatal care. Am J Obstet Gynecol 1994; 171: 1347-55. http://dx. doi. org/10. 1016/0002-9378(94)90159-7.
81. Yu L, Hey E, Doyle L, Farrell B, Spark P, Altman D, et al. Evaluation of the Ages and Stages Questionnaires in identifying children with neurosensory disability in the Magpie Trial follow-up study. Acta Paediatrica 2007; 96: 1803-8. http://dx. doi. org/10. 1111/j. 1651-2227. 2007. 00517. x.
82. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR, for the EPICure Study Group. Neurologic and developmental disability after extremely preterm birth. N Engl J Med 2000; 343: 378-84. http://dx. doi. org/10. 1056/NEJM200008103430601.
83. Balmford J, Borland R, Hammond D, Cummings KM. Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob Res 2011; 13: 94-102. http://dx. doi. org/10. 1093/ntr/ntq215.
84. West R, Zhou X. Is nicotine replacement therapy for smoking cessation effective in the 'real world'? Findings from a prospective multinational cohort study. Thorax 2007; 62: 998-1002. http://dx. doi. org/10. 1136/thx. 2007. 078758.
85. Dempsey D, Jacob P III, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Therapeut 2002; 301: 594-8. http://dx. doi. org/10. 1124/jpet. 301. 2. 594.
86. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003; 5: 13-25. http://dx. doi. org/10. 1093/ntr/5. 1. 13.
87. Benowitz NL, Dempsey DA. Pharmacotherapy for smoking cessation during pregnancy. Nicotine Tob Res 2004; 6(Suppl. 2): S189-202. http://dx. doi. org/10. 1080/14622200410001669169.
88. Ogburn PL Jr., Hurt RD, Croghan IT, Schroeder DR, Ramin KD, Offord KP, et al. Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects. Am J Obstet Gynecol 1999; 181: 736-43. http://dx. doi. org/10. 1016/S0002-9378(99)70521-1.